Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer, on January 9, 2018. The filing serves to update the Company's Bylaws (statuts) to reflect amendments previously adopted at the Shareholders' General Meeting held on June 26, 2017. The updated Bylaws are dated November 10, 2017.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance update and does not contain financial statements or performance data.
Material Changes
The material change reported is the formal restatement of the Company's Bylaws to incorporate amendments approved by shareholders in June 2017. No financial or operational changes are detailed in this document.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document focuses solely on the submission of the updated Bylaws as Exhibit 99.1.
Key Facts for Investors to Verify
- The Company's Bylaws were updated as of November 10, 2017, to reflect shareholder-approved amendments.
- This Form 6-K is incorporated by reference into the Company's registration statements on Form F-3 (333-217086) and Form S-8 (333-204205 and 333-214884).
- The filing contains no financial results or operational updates for the period ending January 9, 2018.